about
Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature ReviewFrequent overexpression of HMGA1 and 2 in gastroenteropancreatic neuroendocrine tumours and its relationship to let-7 downregulationAssessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectumOverexpression of HMGA2 relates to reduction of the let-7 and its relationship to clinicopathological features in pituitary adenomasGenome-wide association study of survival in patients with pancreatic adenocarcinomaExpression of cell adhesion molecules in chordomas: an immunohistochemical study of 16 cases.Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form.Expression of adhesion molecules and Ki-67 in female adnexal tumor of probable Wolffian origin (FATWO): report of two cases and review of the literature.No evidence for interference of h&e staining in DNA testing: usefulness of DNA extraction from H&E-stained archival tissue sections.Prospective study of family history and colorectal cancer risk by tumor LINE-1 methylation level.Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with β-catenin (CTNNB1) status.Characterization of endogenous human Argonautes and their miRNA partners in RNA silencing.Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3) is a marker of unfavourable prognosis in colorectal cancer.Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancerA prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics-related tumor classificationHyperglycemia, insulin resistance, impaired pancreatic β-cell function, and risk of pancreatic cancer.Microsatellite instability and BRAF mutation testing in colorectal cancer prognosticationClinical presentation, recurrence, and survival in patients with neuroendocrine tumors: results from a prospective institutional database.Aspirin use and risk of colorectal cancer according to BRAF mutation statusPrognostic significance of MTOR pathway component expression in neuroendocrine tumors.Analysis of expression and structure of the rat GH-secretagogue/ghrelin receptor (Ghsr) gene: roles of epigenetic modifications in transcriptional regulation.Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: relation to tumor type, size, proliferation, and invasiveness.Reduction of GSTP1 expression by DNA methylation correlates with clinicopathological features in pituitary adenomas.Pituitary adenomas that show a faint GH-immunoreactivity but lack fibrous body: Pit-1 adenoma with endocrinologically low activity.Inactivation of RASSF1A tumor suppressor gene by aberrant promoter hypermethylation in human pituitary adenomas.Tumor-specific downregulation and methylation of the CDH13 (H-cadherin) and CDH1 (E-cadherin) genes correlate with aggressiveness of human pituitary adenomas"Honeycomb Golgi" in Pituitary Adenomas: Not a Marker of Gonadotroph AdenomasExpression of E-cadherin, b-catenin, and Ki-67 in goblet cell carcinoids of the appendix: an immunohistochemical study with clinical correlationRole of E-cadherin, alpha-, beta-, and gamma-catenins, and p120 (cell adhesion molecules) in prolactinoma behaviorExpression of adhesion molecules and cytokeratin 20 in merkel cell carcinomasHistological and immunohistochemical study of composite neuroendocrine-exocrine carcinomas of the stomachDNA methyltransferases 1, 3a, and 3b overexpression and clinical significance in gastroenteropancreatic neuroendocrine tumorsIncreased expression of HMGA1 correlates with tumour invasiveness and proliferation in human pituitary adenomas
P50
Q24289005-610044D6-BE5A-4E7C-8564-B216CFD2FBEFQ24655168-C61D6551-63AD-43BF-ADCB-22AF9DF8D100Q28262150-1C40DA63-F5B5-4FB9-A9E4-540EC29C78A6Q28306491-0ECAA827-AF28-4510-8EC7-CF78D43F8C6EQ28943489-59468D64-77C3-4E16-9781-333E0B2636A5Q33271989-808037B2-07D1-4F0C-806D-28B13BC12E6EQ33352130-9379D048-3B52-489F-8CB1-8624A8AD01CFQ35931240-431C5175-E7EC-4433-A764-B69EE09BEC2CQ36059870-16B3E9C3-3034-4617-9EA8-B7C21B464997Q36535688-725C33C0-11C5-4BE9-AE6A-0FF676B05E15Q36675320-5714EDBD-75AB-4619-9F3C-47E071AF817BQ36725641-EC468DFC-A6DD-4837-9B22-B4D26648070DQ36733283-8B3C0F3D-8084-4E1F-9A22-BC3CF03F7C66Q36926941-9DEE8EAD-6B58-41B3-8A9C-379BF28C3DECQ36974863-A701555D-BCF6-4BA7-82DD-6CBFCF9B00EBQ37021217-C211B13C-9A7B-4D48-956E-B3421AE31C8CQ37075412-737B5FF4-1A6F-4ACF-A470-5B5658C8EE7EQ37085554-B37F20DB-1214-490F-B449-C98D7B533458Q37094281-818588C4-3753-4F60-AC20-A8DA95B32EA0Q37165103-2FDB8E91-A4A2-4528-9D6C-F35A49D0E812Q39506753-3A835699-6014-4CB9-8CF6-AFD998D1C991Q40568889-9D6B2A6C-4C3F-4F32-8341-CBD994B24D1BQ46470681-CF2430B2-A44A-4EBE-931C-2E3BF8282811Q54444228-545E8A64-6312-4284-AEAC-7D7E4EC54654Q54680642-FBCD5302-3012-4842-B489-417AAF500107Q57794449-B2915BAE-6FF6-4D00-B12F-D8DD530CCEA1Q57794725-E9A8055D-248B-44ED-934A-03BBC5FE557CQ74454028-156876B6-1804-4944-9069-DDB97D02DA08Q78656316-B5C03127-9449-4711-ABCB-BE6600007414Q80425901-F193C535-56A9-43EC-B8EA-B7E818319A3FQ81225884-55E69999-DD54-42E7-B0E6-C2C7C1CF6FC4Q84033869-A1A57917-DC50-4DFE-90B5-5986C764DA29Q84202548-501801A8-2751-47BA-81C2-F6341C931237
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Zhi Rong Qian
@ast
Zhi Rong Qian
@en
Zhi Rong Qian
@es
Zhi Rong Qian
@nl
type
label
Zhi Rong Qian
@ast
Zhi Rong Qian
@en
Zhi Rong Qian
@es
Zhi Rong Qian
@nl
prefLabel
Zhi Rong Qian
@ast
Zhi Rong Qian
@en
Zhi Rong Qian
@es
Zhi Rong Qian
@nl
P106
P31
P496
0000-0003-1633-4120